Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of quantifying lysergic acid diethylamide (LSD) and 2,3-dihydro-3-hydroxy-2-oxo lysergide (O-H-LSD) in human plasma

Method of quantifying lysergic acid diethylamide (LSD) and 2,3-dihydro-3-hydroxy-2-oxo lysergide (O-H-LSD) in human plasma

US Patent 11959929 · Granted Apr 16, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin, or2024
Synthesis routes to access MDMA prodrugs by using controlled and non-controlled 2024
Antidepressant-psilocybin co-treatment to assist psychotherapy2023
LSD dose identification2023
MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin or 2022